Abstract: Immune function of an animal can be modulated by administration of a composition that includes algae meal or beta glucan. The algae meal can be made by growing Euglena using particular methods and conditions, including certain continuous, semi-continuous, fed-batch, and repeat batch methods in sterile fermenters. Euglena provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-1,3-glucan. Use of algae meal and beta glucan produced by the disclosed processes can improve the wellbeing of an animal or human, and may augment or even replace the use of antibiotics in certain circumstances.
Type:
Grant
Filed:
May 7, 2013
Date of Patent:
February 21, 2017
Assignee:
Algal Scientific Corporation
Inventors:
Robert Bernard Levine, Jeffrey Richard LeBrun, Geoffrey Paul Horst
Abstract: Immune function of an animal can be modulated by administration of a composition that includes algae meal or beta glucan. The algae meal can be made by growing Euglena using particular methods and conditions, including certain continuous, semi-continuous, fed-batch, and repeat batch methods in sterile fermenters. Euglena provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-1,3-glucan. Use of algae meal and beta glucan produced by the disclosed processes can improve the wellbeing of an animal or human, and may augment or even replace the use of antibiotics in certain circumstances.
Abstract: Immune function of an animal can be modulated by administration of a composition that includes beta glucan. The beta glucan can be derived from Euglena, which provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-(1,3)-glucan. Beta glucan can also be complexed with a metal, such as zinc, and/or can combined with an animal feed component to form an animal feed composition. Use of such compositions can improve the well being of an animal, and may augment or even replace the use of antibiotics in certain circumstances.
Abstract: A wastewater treatment method includes the steps of supplying a wastewater influent having nutrients for a population of phototactic heterotrophic microorganisms to an aerated bioreactor. At least a portion of the nutrients is converted into the phototactic heterotrophic microorganism population. The wastewater influent and the phototactic heterotrophic microorganism population together form a bioreactor effluent that is transferred to a light clarifier. The bioreactor effluent is concentrated in the light clarifier to form a low-solids effluent and a high-solids effluent. The concentration is performed by inducing the population of phototactic heterotrophic microorganisms to phototactically self concentrate through exposure to a light having at least one of an intensity and a wavelength sufficient to cause the phototactic heterotrophic microorganism population to migrate away from a source of the light. The high-solids effluent is then dewatered to form a concentrated biomass paste.